Amylyx Crashes 26% As New ALS Drug Faces A Barrage Of Troubles

Amylyx missed Wall Street's expectations on Thursday amid struggles for its amyotrophic lateral sclerosis drug, and AMLX stock crashed. The post Amylyx Crashes 26% As New ALS Drug Faces A Barrage Of Troubles appeared first on Investor's Business Daily.#amylyx #amlx #amylyxcrashes

Source: Reuters: Health - November 9, 2023 Category: Consumer Health News Source Type: news